Analyse court terme - AB SCIENCE SA : La moyenne mobile sert de résistance.
Le précédent creux vient d'être enfoncé, ceci confirme la tendance baissière. Le prochain objectif est à 4,200 €. Le niveau d'invalidation est au-dessus de 5,350 €.Arguments :
- Le support est enfoncé.
- La résistance est atteinte, elle cause le repli.
- Les cours font un nouveau plus bas historique, la tendance est affirmée.
- La moyenne mobile sert de résistance.
AB Science is a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), a new class of targeted molecules whose action is to modify signaling patways within cells. Co. targets diseases such as cancer, inflammatory diseases and central nervous system diseases, in both human and veterinary medecines. Co. has developed its own portfolio of molecules including masitinib, which has already been registered in Europe and the U.S.A. and is pursuing five phase 3 studies in human medecine, including studies in pancreatic cancer, GIST, metastatic melanoma, and studies in mastocytosis and severe persistent asthma.
DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.